Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Regeneron Pharmaceuticals Inc.

Market open

REGN
/zigman2/quotes/203149337/composite

$

615.47

Change

+3.12 +0.51%

Volume

Volume 143,621

Aug 13, 2020, 12:59 p.m.

Real time quotes

/zigman2/quotes/203149337/composite

Previous close

$ 612.35

$ 615.47

Change

+3.12 +0.51%

Day low

Day high

$607.27

$616.24

Open
Open: 611.49

52 week low

52 week high

$271.37

$664.64

Open

Market cap

$65.15B

Average volume

853,828

P/E ratio

23.83

Rev. per Employee

$906,865

EPS

25.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  4. Dow Gains as Stocks Look Past Dismal Jobs Data

    12:55 p.m. Aug. 5, 2020

    - Ben Levisohn

  6. Regeneron Stock Climbs as Earnings Come in Strong

    9:02 a.m. Aug. 5, 2020

    - Josh Nathan-Kazis

  8. Regeneron shares jump 2.7% premarket

    6:43 a.m. Aug. 5, 2020

    - Ciara Linnane

  9. Regeneron expects fully-recruited clinical trials to remain intact despite pandemic

    6:41 a.m. Aug. 5, 2020

    - Ciara Linnane

  10. Regeneron Q2 revenue $1.952 bln vs. $1.578 bln; FactSet consensus $1.726 bln

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  11. Regeneron Q2 adj. EPS $7.16; FactSet consensus $5.91

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  12. Regeneron Q2 EPS $7.61 vs. $1.68

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  13. Regeneron’s Covid-19 Antibody Looks Promising in Animal Test

    11:24 a.m. Aug. 4, 2020

    - Josh Nathan-Kazis

  15. Buy Merck for Its Unappreciated Pipeline, Says Goldman

    10:47 a.m. Aug. 3, 2020

    - Bill Alpert

  16. Eli Lilly Testing a Covid-19 Antibody Drug in Nursing Homes

    9:16 a.m. Aug. 3, 2020

    - Josh Nathan-Kazis

  20. Roche's rheumatoid arthritis drug fails in COVID-19 trial

    7:24 a.m. July 29, 2020

    - Jaimy Lee

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Regeneron's BLA for Cholesterol Drug Accepted by the FDA

    11:22 a.m. Today

    - Zacks.com

  2. 5 Top-Ranked Stocks Driving ETF as S&P 500 Nears New Highs

    10:15 a.m. Today

    - Zacks.com

  3. Genomic Medicine: Summer 2020 Update

    9:36 a.m. Today

    - Seeking Alpha

  4. After Apple and Tesla, 13 More Stock Splits That Should Come Very Soon

    7:53 a.m. Today

    - 247WallSt.com

  8. Drug/Biotech Stock Q2 Earnings Due on Aug 11: VIR and AUPH

    11:28 a.m. Aug. 10, 2020

    - Zacks.com

  9. Regeneron (REGN) Gets a Hold Rating from Cowen & Co.

    5:08 a.m. Aug. 10, 2020

    - SmarterAnalyst

  11. Biotech's Q2:  Lots Of Candidates That May Deliver Alpha

    12:29 p.m. Aug. 9, 2020

    - Seeking Alpha

  12. Regeneron Pharma prices senior unsecured notes offering

    4:26 p.m. Aug. 7, 2020

    - Seeking Alpha

  13. Alnylam Managing Through Covid-19 Challenges And Executing Well

    12:34 p.m. Aug. 7, 2020

    - Seeking Alpha

  17. Morgan Stanley Maintains a Hold Rating on Regeneron (REGN)

    11:55 a.m. Aug. 6, 2020

    - SmarterAnalyst

  19. Regeneron (REGN) Receives a Hold from RBC Capital

    11:39 a.m. Aug. 6, 2020

    - SmarterAnalyst

  20. 10-Q: ALNYLAM PHARMACEUTICALS, INC.

    8:20 a.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.